SITE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now. SITE is pulling back toward support (141) while the longer-term trend remains bullish (SMA5>SMA20>SMA200). With hedge funds aggressively accumulating and Wall Street sentiment improving (recent RBC upgrade + BofA Buy), the risk/reward favors entering immediately rather than waiting for a “perfect” setup. Near-term upside is capped by consensus targets (147–151), but the setup supports a tactical buy at current levels with an eye on a rebound back above ~145–150.
Trend/price action: Despite today’s -0.9% dip to 142.99, the moving-average stack is bullish (SMA_5 > SMA_20 > SMA_200), signaling the broader uptrend is intact. Momentum: MACD histogram is negative and worsening (-0.666, negatively expanding), which indicates short-term downside pressure/pullback is ongoing. RSI_6 at ~37.9 is leaning toward the lower end of neutral (not deeply oversold), consistent with a pullback rather than a breakdown. Levels: Pivot 145.35 is the key reclaim level; a move back above it improves near-term momentum. Immediate support is S1 141.15 (then S2 138.56). Resistance levels are 149.54 (R1) and 152.13 (R2). Pattern-probability model: Similar-pattern analysis suggests a positive skew (50% chance of gains) with potential magnitude of ~6.4% over a week and ~11.6% over a month—supportive of buying the dip near support.
Intellectia Proprietary Trading Signals: No signal on given stock today.
and BofA initiation at Buy (PT 147).
Event catalyst ahead: Earnings on 2026-02-18 (pre-market) can re-rate the stock if margin/pricing tailwinds show up in guidance.
and Barclays is Equal Weight with 134, implying meaningful downside to some targets.
Latest quarter: 2025/Q3. Growth/margins: Revenue rose to $1.258B (+4.09% YoY) while profitability accelerated—Net Income $59.1M (+33.11% YoY) and EPS $1.31 (+35.05% YoY). Gross margin improved to 34.75 (+2.21% YoY). The mix of modest top-line growth with strong EPS/net income and margin expansion is a constructive trend (operating leverage improving).
Recent rating/target trend: Overall direction has turned more constructive into early 2026. RBC upgraded to Outperform with a $151 target (sees better risk/reward, pricing tailwind, margin expansion). BofA initiated at Buy with a $147 target (expects share gains and EBITDA margin upside). On the cautious side, Stifel kept Hold and lowered PT to $134; Barclays upgraded to Equal Weight but set PT at $134. Wall Street pros: Improving setup into 2026 (pricing and margin tailwinds), share-gain story in a fragmented market, and valuation reset cited as attractive. Wall Street cons: Housing-start softness could linger; some firms still see limited upside or downside to ~$134, implying the stock needs execution/guidance follow-through to justify higher levels.
